Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation status

Blood Cancer J. 2019 May 15;9(6):47. doi: 10.1038/s41408-019-0207-7.

¹ Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
² Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA.
³ Karches Center for Chronic Lymphocytic Leukemia Research, The Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY, USA.
⁴ Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. [email protected].
⁵ Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA. [email protected].
⁶ Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL, USA. [email protected].
⁷ Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA. [email protected].

No abstract available

Publication types